Figure 5.
Representative expression of BCMA, TACI, and BAFF-R, as well as BLyS-binding, on B cells of HIV-viremic, HIV-aviremic, and HIV-negative individuals. A gate was set on CD19-positive B cells, and cells were analyzed for expression of BCMA, TACI, and BAFF-R relative to CD21. Representative profiles from an HIV-viremic patient, an HIV-aviremic patient, and an HIV-negative donor are shown (see Table S1 for complete dataset).